索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]梁平平,仲琳,龚磊,等.成纤维细胞生长因子21对心脏保护作用的研究进展[J].国际心血管病杂志,2016,04:217-220.
点击复制

成纤维细胞生长因子21对心脏保护作用的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年04期
页码:
217-220
栏目:
综述
出版日期:
2016-07-20

文章信息/Info

Title:
-
作者:
梁平平; 仲琳; 龚磊; 杨军
264000 青岛大学附属烟台毓璜顶医院心血管内科(梁平平、仲 琳、杨 军); 生物芯片室(龚 磊)
Author(s):
-
关键词:
成纤维细胞生长因子21; 心血管疾病; 心脏保护作用
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.04.008
文献标识码:
-
摘要:
成纤维细胞生长因子(FGF)21是内源性心脏保护因子,参与多种疾病的病理生理过程,主要功能包括调节糖脂代谢、抗动脉粥样硬化、减少心肌梗死面积和减轻心肌缺血再灌注损伤等。该文主要介绍FGF21在动脉粥样硬化、心肌缺血、内质网应激炎症反应中的生物学作用及其作用机制。
Abstract:
-

参考文献/References

[1] Uebanso T, Taketani Y, Yamamoto H, et al. Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor?[J]. PLoS One, 2011, 6(8): e22976.
[2] Kharitonenkov A, Larsen P. FGF21 reloaded: challenges of a rapidly growing field[J]. Trends Endocrinol Metab, 2011, 22(3): 81-86.
[3] Zhang J, Li Y. Fibroblast growth factor 21, the endocrine FGF pathway and novel treatments for metabolic syndrome[J]. Drug Discov Today, 2014, 19(5): 579-589.
[4] Seo JA, Kim NH. Fibroblast growth factor 21: a novel metabolic regulator[J]. Diabetes Metab J, 2012, 36(1): 26-28.
[5] Ding X, Boney-Montoya J, Owen BM, et al. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism[J]. Cell Metab, 2012, 16(3): 387-393.
[6] Kuro-o M. Klotho and betaKlotho[J]. Adv Exp Med Biol, 2012, 728:25-40.
[7] Yie J, Wang W, Deng L, et al. Understanding the physical interactions in the FGF21/FGFR/beta-Klotho complex: structural requirements and implications in FGF21 signaling[J]. Chem Biol Drug Des, 2012, 79(4): 398-410.
[8] Lundasen T, Hunt MC, Nilsson LM, et al. PPARalpha is a key regulator of hepatic FGF21[J]. Biochem Biophys Res Commun, 2007, 360(2): 437-440.
[9] Galman C, Lundasen T, Kharitonenkov A, et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man[J]. Cell Metab, 2008, 8(2): 169-174.
[10] Lu Y, Liu JH, Zhang LK, et al. Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells[J]. Chin Med J(Engl), 2010, 123(23): 3417-3421.
[11] Patel V, Adya R, Chen J, et al. Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts[J]. PLoS One, 2014, 9(2): e87102.
[12] Lin Z, Wu Z, Yin X, et al. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile[J]. PLoS One, 2010, 5(12): e15534.
[13] Shen Y, Ma X, Zhou J, et al. Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease[J]. Cardiovasc Diabetol, 2013, 12:124.
[14] Lee Y, Lim S, Hong ES, et al. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status[J]. Clin Endocrinol(Oxf), 2014, 80(1): 57-64.
[15] Chow WS, Xu A, Woo YC, et al. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors[J]. Arterioscler Thromb Vasc Biol, 2013, 33(10): 2454-2459.
[16] Shang W, Yu X, Wang H, et al. Fibroblast growth factor 21 enhances cholesterol efflux in THP-1 macrophage-derived foam cells[J]. Mol Med Rep, 2015, 11(1): 503-508.
[17] Wu X, Qi YF, Chang JR, et al. Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(-/-) mice[J]. Heart Vessels, 2015, 30(5): 657-668.
[18] 柳景华, 吕 昀, 张立克,等. 过氧化物酶体增殖物激活受体α诱导内源性成纤维细胞生长因子21表达水平变化对氧化修饰的低密度脂蛋白引起的鼠内皮细胞凋亡的影响[J]. 中华心血管病杂志, 2010, 38(12): 1113-1117.
[19] 李巧元, 柳景华, 吕 昀, 等. 急性冠脉综合征血浆成纤维细胞生长因子21变化的临床意义[J]. 中国介入心脏病学杂志, 2011, 19(2): 69-73.
[20] Liu SQ, Roberts D, Kharitonenkov A, et al. Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue[J]. Sci Rep, 2013, 3:2767.
[21] Joki Y, Ohashi K, Yuasa D, et al. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism[J]. Biochem Biophys Res Commun, 2015, 459(1): 124-130.
[22] Cong WT, Ling J, Tian HS, et al. Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia-reperfusion injury[J]. Can J Physiol Pharmacol, 2013, 91(11): 973-984.
[23] Kim DE, Kim B, Shin HS, et al. The protective effect of hispidin against hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblast cells through Akt/GSK-3 beta and ERK1/2 signaling pathway[J]. Exp Cell Res, 2014, 327(2): 264-275.
[24] Minamino T, Kitakaze M. ER stress in cardiovascular disease[J]. J Mol Cell Cardiol, 2010, 48(6): 1105-1110.
[25] Myoishi M, Hao H, Minamino T, et al. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome[J]. Circulation, 2007, 116(11): 1226-1233.
[26] Doroudgar S, Thuerauf DJ, Marcinko MC, et al. Ischemia activates the ATF6 branch of the endoplasmic reticulum stress response[J]. J Biol Chem, 2009, 284(43): 29735-29745.
[27] Davenport EL, Morgan GJ, Davies FE. Untangling the unfolded protein response[J]. Cell Cycle, 2008, 7(7): 865-869.
[28] Faitova J, Krekac D, Hrstka R, et al. Endoplasmic reticulum stress and apoptosis[J]. Cell Mol Biol Lett, 2006, 11(4): 488-505.
[29] Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response[J]. Nature, 2008, 454(7203): 455-462.
[30] 徐 磊, 张 双, 胡厚祥. 内质网应激与心血管疾病[J]. 国际心血管病杂志, 2013, 42(5): 288-284.
[31] Schaap FG, Kremer AE, Lamers WH, et al. Fibroblast growth factor 21 is induced by endoplasmic reticulum stress[J]. Biochimie, 2013, 95(4): 692-699.
[32] Wan XS, Lu XH, Xiao YC, et al. ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress[J]. Biomed Res Int, 2014, 2014:807874.
[33] Jiang S, Yan C, Fang QC, et al. Fibroblast growth factor 21 is regulated by the IRE1 alpha-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis[J]. J Biol Chem, 2014, 289(43): 29751-29765.
[34] Groenendyk J, Agellon LB, Michalak M. Coping with endoplasmic reticulum stress in the cardiovascular system[J]. Annu Rev Physiol, 2013, 75:49-67.
[35] Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation[J]. Science, 2011, 334(6059): 1081-1086.
[36] Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control[J]. Biochem Soc Trans, 2006, 34(Pt 1): 7-11.
[37] Zhang C, Huang Z, Gu J, et al. Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway[J]. Diabetologia, 2015, 58(8): 1937-1948.
[38] Planavila A, Redondo-Angulo I, Ribas F, et al. Fibroblast growth factor 21 protects the heart from oxidative stress[J]. Cardiovasc Res, 2015, 106(1): 19-31.

备注/Memo

备注/Memo:
基金项目:山东省自然科学基金(ZR2015HM058); 烟台市科技发展计划项目(2013WS224) 作者单位:264000 青岛大学附属烟台毓璜顶医院心血管内科(梁平平、仲 琳、杨 军); 生物芯片室(龚 磊) 通信作者:杨 军,Email:yangjun19640124@163.com
更新日期/Last Update: 2016-07-20